Letermovir for Secondary Prophylaxis of Cytomegalovirus Infection and Disease after Allogeneic Hematopoietic Cell Transplantation: Results from the French Compassionate ProgramChristine Robin, Catherine Cordonnier, Maud D’Aveni et al.|Biology of Blood and Marrow Transplantation|2020Cited by 77